chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient received expired dose beyind expiratory date 03OCT2021; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received expired dose beyond expiratory date 03OCT2021) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. No Medical History information was reported.    On 08-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received expired dose beyond expiratory date 03OCT2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient received expired dose beyind expiratory date 03OCT2021) outcome was unknown. Not Provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No Treatment medications were reported. The vaccine was refrigerated on 04-NOV-2021. The patient had no adverse events. The vial had no temperature excursion.
Patient reported feeling flushed, itching, and redness all over body about 30 minutes after injection. 50mg of IM Benadryl given in the right deltoid. Patient tolerated well. No signs of respiratory distress. Observed 30 mins after Benadryl given. Patient alert and oriented. Left in accompany of coworker. Instructed to call 911 if signs of respiratory distress.
Red, hot , hard at vaccination site on R ant. thigh, hard to walk, painful to touch.  Began evening of Vaccinations, and at f/u 02/07/05. was still mildly re, hard and sore to touch, but walking without difficulty.
Low diastolic blood pressure (38-46 range); Low blood pressure readings (under 50); Method of testing - Apple Watch and wrist monitor.
Pt reports hives on entire body, lips. Have been intermittent since vaccine #2 administered.  Pt sought care for this in local urgent care on 7/27/21 but no active sxs at that time.
Not eating for quite a few days,Totally out of it; COVID-19; MIssed dose; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), DECREASED APPETITE (Not eating for quite a few days,Totally out of it) and PRODUCT DOSE OMISSION ISSUE (MIssed dose) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (MIssed dose). On 25-Feb-2021, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced DECREASED APPETITE (Not eating for quite a few days,Totally out of it). At the time of the report, COVID-19 (COVID-19), DECREASED APPETITE (Not eating for quite a few days,Totally out of it) and PRODUCT DOSE OMISSION ISSUE (MIssed dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No Treatment information was not provided.
fever to 101; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was captured as adult as per the vaccine indication. The age at vaccination was not reported. After receiving Shingrix, the patient experienced fever. The patient's body temperature was 101 degree Fahrenheit. The reporter wanted to know was it better to take Tylenol for fever to 101 after Shingrix or not to medicate.
For lot 083J21A put in the fridge on 07Feb2022, and date of administration on 12-Apr-2022; Expired doses of Moderna COVID-19 were administered beyond the beyond use date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses of Moderna COVID-19 were administered beyond the beyond use date.) and PRODUCT STORAGE ERROR (For lot 083J21A put in the fridge on 07Feb2022, and date of administration on 12-Apr-2022) in a 63-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 083J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses of Moderna COVID-19 were administered beyond the beyond use date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (For lot 083J21A put in the fridge on 07Feb2022, and date of administration on 12-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired doses of Moderna COVID-19 were administered beyond the beyond use date.) and PRODUCT STORAGE ERROR (For lot 083J21A put in the fridge on 07Feb2022, and date of administration on 12-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  Patient took booster dose of Moderna and took total 3 doses.Patient received vaccine on 07 Feb 2022. Lot number 083J21A was refrigerated on 7-Feb-2022. Vial did not undergo any temperature excursion.  No treatment medication was reported by reporter.
This is an initial spontaneous report from a contactable nurse reporting for a patient. This 6-month-old male patient received a dose of PREVNAR 13 on 04JAN2011 at 0.5ml, as routine vaccination. The relevant medical history of the patient included genital urinary reflux since 21JUN2010. The relevant concomitant medications included multivitamins since an unknown date at an unknown dose and frequency, as a supplement. The past drug history of the patient was unknown. It was reported that the patient developed swollen and protruding tongue along with increased "work of breathing" and increased spitting up within half an hour of the vaccination on 04JAN2011. There was no relevant laboratory data. There were no therapeutic measures performed. At the time of the report the patient was not experiencing the increasing "work of breathing" and increased spitting up, however he had not recovered from the swollen and protruding tongue.
Patient had flushing/sweating, dizziness, lightheaded, diaphoretic, lips tingling, slight blurred vision, anxious. Given water, juice, graham crackers. Symptoms improved, stable, patient released from vaccination site.
pt verbalized weakness, fainted, hands & feet turned inward towards body & knees upward toward chest, pale skin,became able to speak;BP 130/80, pulse 72;
Pt received 2nd dose on 06/15/2018. After receiving the shot pt developed cramping in the arm, that cause weekness in the arm. Eventually the arm started to feel numb radiating to the fingers.  Pt saw a physician and couple nerve specialists to diagnose the pain and numbness that never went away for 5 months after receiving the shot. Pt still has numbness and weakness in the arm.
Child itching face and rash noted by child's teacher after the Flumist was given. Rash noted by school nurse on neck, bridge of nose, forehead and rash and some swelling on both cheeks. Tsp Benadryl given and parents notified. Rash gone the next day.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patients were vaccinated with the doses of improperly stored ROTATEQ lot # K016278, expiration date 21-APRI-2016 (dose, route and site of administration were not reported). Concomitant medications were not reported. No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.
Fever for 3 days after vaccination, fatigue on and off for 7 days after administration. At the same time, left arm swelling with discoloration and bruising. 1-2 days later, left axilla pain increases to 9/10 pain. At day 5, he reports chest pain after being asked specifically if he feels it. He is active at summer camp and is uninhibited with activities today.
rash and itching presented about 72 hours following immunization, flared up off and on for 1 week
Chills, and fever that spiked as high as 102.7 Degrees F....
Child received DTap injection 11/18/02. Seen 11/19/02 with erythematous warm and hard right thigh 9cm diameter.
I was extremely fatigued and had a headache after the second dose. Arm was very sore and had some body aches.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. The patient's medical history, current conditions and concomitant medication were not reported. On 06-AUG-2017, the patient was vaccinated with improperly stored ZOSTAVAX lot # M042850 and expiry date: 18-JAN-2018 (dose and route were not reported) for prophylaxis. The pharmacist was unable to provide the lot number and expiration date for the properly stored sterile diluent that were used to reconstitute the vaccines. The vaccine was exposed to a temperature frame of 15 Fahrenheit to 46 Fahrenheit for 11 hours and 2 minutes. There were no previous temperature excursions. The call was because of a digital data logger. No adverse effects were reported. No additional information is available. No product quality complaint involved. This is one of the two reports from the same reporter.; Sender's Comments: US-009507513-1708USA006544:
Ache; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 47 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 09Jun2021 (Lot number: EW0185, Expiration Date: 31Aug2021) at the age of 47 years as dose 1, 0.3 ml single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "recovered" (2021), described as "Ache". Therapeutic measures were not taken as a result of pain.  Additional information: Emergency Room? No, Physician Office? No, Prior Vaccinations (within 4 weeks): None. He got the second shot three weeks ago. The first shot nothing happened. Once he got the second shot and about two days later his arms, joints started to feel pain. It has been going on three weeks now.He stated after getting the Pfizer COVID shot when he squeezes his fist it hurts around the elbow. Initially he declined to continue with report. Stated he is meeting someone about a job. However, three weeks is a long time to have this pain. Caller went on to say, he has not done anything to make his arm hurt. He stated maybe the second shot, maybe the nurse when she poked him inside it touched the bone. He does not know if should feel that. The first shot he felt nothing. When he was given the second shot it seemed that it hit the bone. Then two days later at night he was sore. Then the next day the soreness stopped. He never had the flu or fever. However, it progressed to his arm, joints hurting. His arm, joint felt like pain. It started he believes 02Jul2021. The third day it was the worst. He still feels it now, but confirmed outcome currently as the same. He read on line that people may have joint pain a couple days and now he have been having this pain for three weeks now. If he lifts heavy stuff he has pain. If he straightens his muscle it hurts at the elbow. Consumer sated, "I called Friday, I had a vaccine shot, the second one and it has affected my arm and I called Friday already to you guys and she gave me a number, if you want the number, the confirmation number or something and she told me to call this number. So, because when I got first shot, when I got it, it was okay, it just ache for one day and then the next day, it goes away and then when I got the second shot on 30Jun2021 (not clarified) and then the second day in the morning, my elbow and around elbow too, it seems like when I grip my fist together, it hurts there and if I lift something, grips my fist and pull up, it hurts and it has been three weeks that is why (sentence incomplete). I looked online and it says it is for couple of days, it is not couple of days, it is three weeks."  Follow-up attempts are completed. No further information is expected.
atarted coughing 10/28/19 around 8:30pm c/o ongoing coughing, wheezing, congested, weakness not eating.. tx 10/31/19 depo medrol, abluterol aerosol, antibiotic, cough med
Patient arrived to ED via EMS after wife called reporting the patient became acutely dizzy, diaphoretic, and short of breath during a bowel movement. Patient was found to have COVID-19 via rapid swab with basilar opacities and effusions noted on X-ray. The patient had an elevated lactate of 3.9 and was in AKI with a serum creatinine of 2.36 (baseline 1.5 on 3/26/21). The patient will be admitted to the hospital. The patient has received azithromycin and ceftriaxone in the ED, as well as a fluid bolus of 500 mL NS. Patient is not hypoxic.
Fever, severe pain & mild swelling in leg; No redness, reduced motion; Prior problem w/DTP, only gets DT now;
Nausea; Vomiting; Headache; Clavicle tenderness; Arm pain; Fatigue; This is a spontaneous report from a contactable nurse, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on an unknown date in Aug2021 at 07:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) and clindamycin (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. On 28Aug2021 at 16:45, the patient experienced nausea, vomiting, headache, clavicle tenderness, arm pain and fatigue. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nausea, vomiting, headache, clavicle tenderness, arm pain and fatigue were resolving at the time of this report.
Chest tightness/heart rate > 100 = around 7:30pm-8pm. After 8pm until approximately 11pm = chest tightness resolved, red/dry eyes began, nasal congestion began. Pt took TYLENOL and BENADRYL.
Bells Palsy type sensory reaction; Spots on her chin and cheek leftover from Shingles; This is a spontaneous report from a contactable consumer (another friend of daughter). A 27-year-old female patient received first dose of the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE formulation: Solution for injection, lot number: unknown), via unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced bells palsy type sensory reaction and spots on her chin and cheek leftover from shingles on 23Jan2021. The reported stated that the patient took the first dose of the vaccine and because of the adverse events she experienced, her doctors have told her she cannot take the second dose. Reporter added that her daughter had a quantitative antibody test done after the first shot and the count results were 77.74 milliliters. Reporter wants to know how much protection from Covid does this result give her daughter. She had Spots on her chin and cheek leftover from Shingles. She had an appt. today with the dermatologist. They gave her almost like a bleaching thing and something for the itch. She developed Bells Palsy type sensory reaction was a reaction to the reaction. She was so sick the first 3 days and the 4 day she developed the shingles, bells palsy type reaction. She never had chickenpox. She was the first age group that got Varicella before kindergarten. She never got chicken pox so to get shingles and never had chicken pox, only 22% of the population gets that. 78% of the people that get the vaccine don't get shingles. But yet her antibodies for the varicella zoster was off the roof after the vaccine. It was over 3000 and her face is proof of it. The patient underwent lab tests and procedures which included antibody test: 77.74 milliliters and magnetic resonance imaging: unknown result. Therapeutic measures were taken as a result of spots on her chin and cheek leftover from shingles. The outcome of the events was unknown.
arm where she received the injection is really hurting bad to the elbow/felt sore on her arm where the first dose was placed in and it is like on side and right on her elbow; arm where she received the injection is really hurting bad to the elbow/felt sore on her arm where the first dose was placed in and it is like on side and right on her elbow; This is a spontaneous report from a contactable consumer. A 75-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL3248), first dose via an unspecified route of administration, administered in Arm on 29Jan2021, single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, Sjogren's, Lung problems, from an unknown date. The patient had a flu shot and experienced sore on her arm. Concomitant medications included mycophenolate mofetil hydrochloride (CELLCEPT); insulin (INSULIN); sitagliptin phosphate (JANUVIA). Patient experienced her arm where she received the injection is really hurting bad to the elbow, she took Tylenol and she would like to know if she can put heat on the site to decrease the pain. The outcome of the event was unknown.
Hard to breath, chest pain, heart palpitations, abdominal pain in lower right quadrant.  Intermittent pain that can be an 8 out of 10 at times.  Constant 3 out of 10 throughout the day.
I am experiencing numbness to my lips and tongue, increased heart-rate, pounding heartbeat, shakiness, facial flushing/warmth. This started the day after vaccination 9/8/21 and continues into today 9/10/21 with no lessening of symptoms.
Received vaccine administered high up on shoulder. Shoulder pain with arm movement. Began shortly after. After seeing several doctors and taking medication for pain condition developed and diagnosed as torn shoulder cuff tendon. I think vaccination contributed to this condition.
I have been having general weakness in both legs, swelling. I went to the doctor, he ordered x-rays, vein and arterial scans. They did not show anything. My insurance finally agreed for me to have an MRI, the MRI showed that I have a cyst in my both legs. I am currently wearing compression stockings to help with the swelling.
Patient seen for 2 month check up 6/28/04. Exam WNL. Received 2 month shots; DTaP #1, HIB and Hep B #1, IPV #1, and Prevnar #1. Tolerated well. Office notified 6/30/04 of patient's death on 6/29/04 while asleep at babysitters.  Nurse follow up on 06/30/04 states: "None."
This spontaneous case was reported by a consumer and describes the occurrence of SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (the second dose caused SIRVA), ASTHENIA (loss of strength), MOBILITY DECREASED (drastically reduced range of motion), MUSCULOSKELETAL DISCOMFORT (how to get his shoulder back to where it used to be) and ARTHRALGIA (pain) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included LOSARTAN and ATORVASTATIN for Blood pressure abnormal.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intra-articular) dosage was changed to 1 dosage form. On 04-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (SIRVA is an improperly placed vaccination, instead of it going into the muscle, it went into his joint, the fluid filled sac around the joint.). In 2021, the patient experienced SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (the second dose caused SIRVA), ASTHENIA (loss of strength), MOBILITY DECREASED (drastically reduced range of motion), MUSCULOSKELETAL DISCOMFORT (how to get his shoulder back to where it used to be) and ARTHRALGIA (pain). On 04-Mar-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (SIRVA is an improperly placed vaccination, instead of it going into the muscle, it went into his joint, the fluid filled sac around the joint.) had resolved. At the time of the report, SHOULDER INJURY RELATED TO VACCINE ADMINISTRATION (the second dose caused SIRVA), ASTHENIA (loss of strength), MOBILITY DECREASED (drastically reduced range of motion), MUSCULOSKELETAL DISCOMFORT (how to get his shoulder back to where it used to be) and ARTHRALGIA (pain) outcome was unknown.            The treatment history was not provided. Patient sent for MRI scan on a unknown date in which the results are inconclusive.
rash on the face; feels like sunburn/ feels like she has a sunburn; spots on both arm more intense on the left arm, spots on chest; muscle pain; arm pain; headache; She is experiencing redness in her face; feels very flushed; This is a spontaneous report from a contactable consumer or other non hcp (patient) via medical information team reported that:  A 27-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown), dose 1 via an unspecified route of administration on 14Apr2021 11:30 (at the age of 27 years old) as dose 1, single for covid-19 immunisation. Medical history included cardiac disorder, peripheral swelling and allergy to arthropod sting from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. Prior to vaccination the Patient had heart problem and consulted with her cardiologist, fluid and swelling of the feet, blood stay on the feet. On an unspecified date, the patient experienced rash on the face, feels like sunburn/ feels like she has a sunburn, spots on both arm more intense on the left arm, spots on chest, muscle pain, arm pain, headache, she is experiencing redness in her face and feels very flushed. The outcome of the events was unknown.  Follow-up #1(14Apr2021): This is a follow-up spontaneous report from a Pfizer sponsored program. A contactable female consumer (patient) reported that:   No follow-up attempts are needed; information about lot/batch number cannot be obtained.